Paper7657280
A randomized, double-blind, placebo-controlled trial of ursodeoxycholic acid in primary biliary cirrhosis.
Combes B and 9 others. Hepatology, 1995. Cited by 265 papers, by iCite.
Cite this record
ConductScience Library. A randomized, double-blind, placebo-controlled trial of ursodeoxycholic acid in primary biliary cirrhosis. Papers, record 7657280. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7657280
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Liver Cirrhosis, Biliary | Major topic |
| Ursodeoxycholic Acid | Major topic |
| Adult | |
| Bile | |
| Bilirubin | |
| Double-Blind Method | |
| Female | |
| Humans | |
| Liver | |
| Male | |
| Middle Aged | |
| Placebos | |
| Time Factors | |
| Treatment Failure |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| M01-RR00065 | NCRR NIH HHS | United States | M01RR000065 | PubMed and NIH | NIH RePORTER |
| M01-RR00125 | NCRR NIH HHS | United States | M01RR000125 | PubMed and NIH | NIH RePORTER |
| M01-RR00633 | NCRR NIH HHS | United States | M01RR000633 | PubMed and NIH | NIH RePORTER |
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT00006168 | Ursodiol-Methotrexate for Primary Biliary Cirrhosis | Background |
Source ClinicalTrials.gov
Cited by65
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 265 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41898408 | Potential Therapeutic Strategies for Steatosis, Oxidative Stress, Inflammation, and Fibrosis in Liver Disease. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/41898408 | PubMed |
| 41440960 | The Personalized Management of Primary Biliary Cholangitis in the Era of Precision Medicine: Current Challenges and Future Perspectives. | J Pers Med | 2025 | https://conductscience.org/library/papers/41440960 | PubMed |
| 40977287 | Non-Response to Obeticholic Acid Is Associated With Heightened Risks of Developing Clinical Events in Primary Biliary Cholangitis. | Aliment Pharmacol Ther | 2026 | https://conductscience.org/library/papers/40977287 | PubMed |
| 40568038 | Primary biliary cholangitis: A historical perspective from xanthomatous lesions to modern molecular biology. | World J Gastrointest Pathophysiol | 2025 | https://conductscience.org/library/papers/40568038 | PubMed |
| 40115760 | Bile acid therapy for primary biliary cholangitis: Pathogenetic validation. | World J Exp Med | 2025 | https://conductscience.org/library/papers/40115760 | PubMed |
| 38178006 | Pharmacotherapy for primary biliary cholangitis: an assessment of medication candidacy and rates of treatment. | BMC Gastroenterol | 2024 | https://conductscience.org/library/papers/38178006 | PubMed |
| 37408803 | Emerging Therapeutic Strategies in The Fight Against Primary Biliary Cholangitis. | J Clin Transl Hepatol | 2023 | https://conductscience.org/library/papers/37408803 | PubMed |
| 36910199 | Biological synthesis of ursodeoxycholic acid. | Front Microbiol | 2023 | https://conductscience.org/library/papers/36910199 | PubMed |
| 33486884 | Rodent models of cholestatic liver disease: A practical guide for translational research. | Liver Int | 2021 | https://conductscience.org/library/papers/33486884 | PubMed |
| 32039371 | New treatments/targets for primary biliary cholangitis. | JHEP Rep | 2019 | https://conductscience.org/library/papers/32039371 | PubMed |
| 31970467 | Emerging therapies for PBC. | J Gastroenterol | 2020 | https://conductscience.org/library/papers/31970467 | PubMed |
| 30859149 | A Randomized, Controlled, Phase 2 Study of Maralixibat in the Treatment of Itching Associated With Primary Biliary Cholangitis. | Hepatol Commun | 2019 | https://conductscience.org/library/papers/30859149 | PubMed |
| 30632051 | Treatment of Fatigue in Primary Biliary Cholangitis: A Systematic Review and Meta-Analysis. | Dig Dis Sci | 2019 | https://conductscience.org/library/papers/30632051 | PubMed |
| 29928160 | Update on New Drugs and Those in Development for the Treatment of Primary Biliary Cholangitis. | Gastroenterol Hepatol (N Y) | 2018 | https://conductscience.org/library/papers/29928160 | PubMed |
| 29593060 | The British Society of Gastroenterology/UK-PBC primary biliary cholangitis treatment and management guidelines. | Gut | 2018 | https://conductscience.org/library/papers/29593060 | PubMed |
| 29520309 | Latest development in the synthesis of ursodeoxycholic acid (UDCA): a critical review. | Beilstein J Org Chem | 2018 | https://conductscience.org/library/papers/29520309 | PubMed |
| 29404429 | Update on pharmacotherapies for cholestatic liver disease. | Hepatol Commun | 2017 | https://conductscience.org/library/papers/29404429 | PubMed |
| 29051789 | Novel strategies and therapeutic options for the management of primary biliary cholangitis. | Ther Adv Gastroenterol | 2017 | https://conductscience.org/library/papers/29051789 | PubMed |
| 28350426 | Pharmacological interventions for primary biliary cholangitis: an attempted network meta-analysis. | Cochrane Database Syst Rev | 2017 | https://conductscience.org/library/papers/28350426 | PubMed |
| 27700211 | Primary Biliary Cholangitis: Medical and Specialty Pharmacy Management Update. | J Manag Care Spec Pharm | 2016 | https://conductscience.org/library/papers/27700211 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7657280
GET https://conductscience.org/api/papers/v1/7657280/cited_by?page=2